*/
Casey Randall of AlphaBiolabs discusses the benefits of Non-Invasive Prenatal Paternity testing for the Family Court
Uncertainty surrounding a child’s paternity can cause significant complications in cases involving safeguarding, child maintenance, or parental responsibility, where the question of paternity can delay critical decisions, complicate care planning, and heighten tensions between parties.
While standard paternity DNA tests are now well understood and frequently used in the legal sector, many legal professionals are still not aware that paternity disputes can also be resolved before the child is born.
Thanks to developments in DNA testing, Non-Invasive Prenatal Paternity testing (NIPP) offers a safe, scientifically robust solution for determining paternity during pregnancy, with no risk to the mother or unborn child.
NIPP testing allows paternity to be established from as early as 7 weeks into pregnancy, with only a blood sample and cheek (buccal) swabs from the mother and cheek swabs from the alleged father(s) required.
Expert geneticists extract the baby’s DNA profile from foetal DNA found in the mother’s bloodstream and compare this with the DNA profile of the alleged father. The biological father will share DNA with the baby at every tested marker.
Unlike invasive forms of prenatal paternity testing which require cells to be obtained from the amniotic fluid or the placenta – carrying a small risk of miscarriage – NIPP testing is 100% risk free for mother and baby.
AlphaBiolabs’ NIPP test is the most advanced available and we are the only UK laboratory to hold UKAS 17025 accreditation for NIPP testing.
Establishing paternity during pregnancy offers clear advantages for family law professionals, social workers and local authorities involved in complex or time-sensitive family law matters.
Where paternity is in doubt, timely resolution can reduce conflict, accelerate proceedings, and ensure the welfare of the unborn child is prioritised.
NIPP testing is particularly beneficial in:
AlphaBiolabs’ NIPP testing represents the gold standard in prenatal paternity testing, analysing up to 153 DNA markers for unparalleled accuracy, and making it possible to confirm paternity from 7 weeks into pregnancy.
More reasons to choose AlphaBiolabs:
For more information, contact our New Enquiry team on 0333 600 1300/ testing@alphabiolabs.com or complete our online quote form https://www.alphabiolabs.co.uk/legal-test-forms/, and a member of the team will be happy to discuss the requirements of your case.
Uncertainty surrounding a child’s paternity can cause significant complications in cases involving safeguarding, child maintenance, or parental responsibility, where the question of paternity can delay critical decisions, complicate care planning, and heighten tensions between parties.
While standard paternity DNA tests are now well understood and frequently used in the legal sector, many legal professionals are still not aware that paternity disputes can also be resolved before the child is born.
Thanks to developments in DNA testing, Non-Invasive Prenatal Paternity testing (NIPP) offers a safe, scientifically robust solution for determining paternity during pregnancy, with no risk to the mother or unborn child.
NIPP testing allows paternity to be established from as early as 7 weeks into pregnancy, with only a blood sample and cheek (buccal) swabs from the mother and cheek swabs from the alleged father(s) required.
Expert geneticists extract the baby’s DNA profile from foetal DNA found in the mother’s bloodstream and compare this with the DNA profile of the alleged father. The biological father will share DNA with the baby at every tested marker.
Unlike invasive forms of prenatal paternity testing which require cells to be obtained from the amniotic fluid or the placenta – carrying a small risk of miscarriage – NIPP testing is 100% risk free for mother and baby.
AlphaBiolabs’ NIPP test is the most advanced available and we are the only UK laboratory to hold UKAS 17025 accreditation for NIPP testing.
Establishing paternity during pregnancy offers clear advantages for family law professionals, social workers and local authorities involved in complex or time-sensitive family law matters.
Where paternity is in doubt, timely resolution can reduce conflict, accelerate proceedings, and ensure the welfare of the unborn child is prioritised.
NIPP testing is particularly beneficial in:
AlphaBiolabs’ NIPP testing represents the gold standard in prenatal paternity testing, analysing up to 153 DNA markers for unparalleled accuracy, and making it possible to confirm paternity from 7 weeks into pregnancy.
More reasons to choose AlphaBiolabs:
For more information, contact our New Enquiry team on 0333 600 1300/ testing@alphabiolabs.com or complete our online quote form https://www.alphabiolabs.co.uk/legal-test-forms/, and a member of the team will be happy to discuss the requirements of your case.
Casey Randall of AlphaBiolabs discusses the benefits of Non-Invasive Prenatal Paternity testing for the Family Court
Chair of the Bar reflects on 2025
Q&A with criminal barrister Nick Murphy, who moved to New Park Court Chambers on the North Eastern Circuit in search of a better work-life balance
Revolt Cycling in Holborn, London’s first sustainable fitness studio, invites barristers to join the revolution – turning pedal power into clean energy
Rachel Davenport, Co-founder and Director at AlphaBiolabs, reflects on how the company’s Giving Back ethos continues to make a difference to communities across the UK
By Marie Law, Director of Toxicology at AlphaBiolabs
AlphaBiolabs has made a £500 donation to Sean’s Place, a men’s mental health charity based in Sefton, as part of its ongoing Giving Back initiative
Professor Dominic Regan and Seán Jones KC present their best buys for this holiday season
Little has changed since Burns v Burns . Cohabiting couples deserve better than to be left on the blasted heath with the existing witch’s brew for another four decades, argues Christopher Stirling
Six months of court observation at the Old Bailey: APPEAL’s Dr Nisha Waller and Tehreem Sultan report their findings on prosecution practices under joint enterprise
Despite its prevalence, autism spectrum disorder remains poorly understood in the criminal justice system. Does Alex Henry’s joint enterprise conviction expose the need to audit prisons? asks Dr Felicity Gerry KC
With automation now deeply embedded in the Department for Work Pensions, Alexander McColl and Alexa Thompson review what we know, what we don’t and avenues for legal challenge